Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $10.80 is 35.17% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 11.21||$ 15.41|
|Low:||$ 10.33||$ 7.99|
Company Description (as filed with the SEC)
To deliver curative cell therapies to patients with serious and life-threatening medical conditions. Overview We are a clinical stage biopharmaceutical company leveraging our proprietary technology to develop cell therapies that are designed to cure cancer and rare, serious hematologic diseases. While cell therapies have the potential to address a variety of diseases, they are limited by availability of donor cells, matching a donor to the patient, and the decline in donor cell functionality when expanding the cells to achieve a therapeutic dose. We have leveraged our nicotinamide-, or NAM-, based cell expansion technology to develop a pipeline of products designed to address the limitations of cell therapies. Our proprietary technology is designed to allow for the proliferation of donor cells while maintaining the cells' functional therapeutic characteristics, which, if approved, will provide a treatment alternative for patients. ... More ...
Nasdaq Official Price
Jan. 18, 2019
Jan. 18, 2019